Hematolymphoproliferative malignancies : the impact of lifestyle, organ transplantation and genetic susceptibility
Author: Fernberg, Pia
Date: 2009-02-20
Location: Hillarpsalen, Retzius väg 8
Time: 13.00
Department: Institutionen för medicinsk epidemiologi och biostatistik / Department of Medical Epidemiology and Biostatistics
View/ Open:
thesis.pdf (1.613Mb)
Abstract
During the past decades Non-Hodgkin lymphoma (NHL) has demonstrated an
immense increase in incidence globally, among almost all age and race
groups as well as in both genders. In the search for causes, none of the
known risk factors can alone or together entirely explain this trend.
This thesis aims to answer a number of research inquiries with regard to
NHL but also other hematolymphoproliferative malignancies. Firstly, we
sought to estimate the influence of various forms of tobacco use and body
mass index on the risk of NHL, Hodgkin lymphoma (HL), leukemia and
multiple myeloma. Secondly, we aimed to disentangle the relative
importance of putative determinants of NHL risk in the organ transplant
setting, including characteristics of donor and recipient,
immunosuppressive medications and infectious complications. Thirdly, our
objective was to explore the role of genetic variation in translocation
breakpoint genes (BCL2, CCND1), the protooncogene MYC and
immunoregulatory genes (TNF, IL-10) in the etiology of NHL.
In a large cohort of more than 330,000 construction workers attending regular health check-ups we employed prospectively gathered exposure information on tobacco use and BMI to analyze the incidence rate ratio (IRR) of NHL and HL in a Cox proportional hazards regression model. Tobacco smoking, oral moist snuff use and BMI were all unrelated to NHL. However, among long term users of oral moist snuff (>30 years), an indication of an excess risk of HL was observed (IRR 3.78, 95% confidence interval [95% CI] 1.23-11.6).
In a subsequent study of the construction workers cohort we computed IRR for acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphatic leukemia (ALL) and multiple myeloma (MM) in relation to tobacco use and BMI, applying essentially the same methods. In this investigation, the study population was restricted to male workers and attained age was used as the time scale in the Cox model. Current smoking was associated with a 50% increased risk of AML (95% CI 1.06-2.11).
Within a cohort (n= 5391) of organ transplant recipients (1970-1997) we designed a nested case control study comprising 37 cases of NHL and 97 controls. Odds ratios (OR) were estimated in a conditional logistic regression model. Treatment with antithymocyte globulin (ATG) conferred a five-fold elevated risk of NHL (95% CI 2.17-14.3). The excess risk was more pronounced for a high average daily dose of ATG. Further, having a herpes virus group infection was associated with a five-fold excess risk of NHL (OR 4.89, 95% CI 1.88-12.7), most likely to be driven by Epstein Barr virus.
In a case-control study of 2410 incident cases of NHL and 1963 matched controls selected from the Swedish and Danish population registers, subjects took part in a telephone interview and provided blood specimens for genotyping. OR and 95% CI were computed in multivariate logistic regression analyses. No relationship between investigated polymorphisms in BCL2, CCND1 or MYC and NHL could be discerned. TNF rs1800629 minor allele homozygocity was associated with a 50% greater risk of NHL (OR 1.52, 95% CI, 1.06-2.18) as well as a two-fold increased risk of T-cell lymphoma and Mantle cell lymphoma, respectively. IL10 rs1800890 minor allele homozygocity conferred a higher risk of diffuse large B-cell lymphoma (OR 1.45, CI 1.10-1.90) and Mantle cell lymphoma (OR 1.83, 95% CI 1.08-3.12).
In a large cohort of more than 330,000 construction workers attending regular health check-ups we employed prospectively gathered exposure information on tobacco use and BMI to analyze the incidence rate ratio (IRR) of NHL and HL in a Cox proportional hazards regression model. Tobacco smoking, oral moist snuff use and BMI were all unrelated to NHL. However, among long term users of oral moist snuff (>30 years), an indication of an excess risk of HL was observed (IRR 3.78, 95% confidence interval [95% CI] 1.23-11.6).
In a subsequent study of the construction workers cohort we computed IRR for acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphatic leukemia (ALL) and multiple myeloma (MM) in relation to tobacco use and BMI, applying essentially the same methods. In this investigation, the study population was restricted to male workers and attained age was used as the time scale in the Cox model. Current smoking was associated with a 50% increased risk of AML (95% CI 1.06-2.11).
Within a cohort (n= 5391) of organ transplant recipients (1970-1997) we designed a nested case control study comprising 37 cases of NHL and 97 controls. Odds ratios (OR) were estimated in a conditional logistic regression model. Treatment with antithymocyte globulin (ATG) conferred a five-fold elevated risk of NHL (95% CI 2.17-14.3). The excess risk was more pronounced for a high average daily dose of ATG. Further, having a herpes virus group infection was associated with a five-fold excess risk of NHL (OR 4.89, 95% CI 1.88-12.7), most likely to be driven by Epstein Barr virus.
In a case-control study of 2410 incident cases of NHL and 1963 matched controls selected from the Swedish and Danish population registers, subjects took part in a telephone interview and provided blood specimens for genotyping. OR and 95% CI were computed in multivariate logistic regression analyses. No relationship between investigated polymorphisms in BCL2, CCND1 or MYC and NHL could be discerned. TNF rs1800629 minor allele homozygocity was associated with a 50% greater risk of NHL (OR 1.52, 95% CI, 1.06-2.18) as well as a two-fold increased risk of T-cell lymphoma and Mantle cell lymphoma, respectively. IL10 rs1800890 minor allele homozygocity conferred a higher risk of diffuse large B-cell lymphoma (OR 1.45, CI 1.10-1.90) and Mantle cell lymphoma (OR 1.83, 95% CI 1.08-3.12).
List of papers:
I. Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Adami J (2006). "Tobacco use, body mass index and the risk of malignant lymphomas--a nationwide cohort study in Sweden." Int J Cancer 118(9): 2298-302
Pubmed
II. Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Zendehdel K, Adami J (2007). "Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden." Cancer Res 67(12): 5983-6
Pubmed
III. Fernberg P, Adami J, Odenbro Å, Bellocco R, Tufveson G, Höglund P, Lindelöf B, Pawitan Y, Ekström Smedby K (2009). "Determinants of non-Hodgkin lymphoma risk in solid organ transplant recipients." (Submitted)
IV. Fernberg P, Chang E, Duvefeldt K, Hjalgrim H, Eloranta S, Meden Sørensen K, Porwit A, Humphreys K, Melbye M, Ekström Smedby K (2009). "Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma." (Submitted)
I. Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Adami J (2006). "Tobacco use, body mass index and the risk of malignant lymphomas--a nationwide cohort study in Sweden." Int J Cancer 118(9): 2298-302
Pubmed
II. Fernberg P, Odenbro A, Bellocco R, Boffetta P, Pawitan Y, Zendehdel K, Adami J (2007). "Tobacco use, body mass index, and the risk of leukemia and multiple myeloma: a nationwide cohort study in Sweden." Cancer Res 67(12): 5983-6
Pubmed
III. Fernberg P, Adami J, Odenbro Å, Bellocco R, Tufveson G, Höglund P, Lindelöf B, Pawitan Y, Ekström Smedby K (2009). "Determinants of non-Hodgkin lymphoma risk in solid organ transplant recipients." (Submitted)
IV. Fernberg P, Chang E, Duvefeldt K, Hjalgrim H, Eloranta S, Meden Sørensen K, Porwit A, Humphreys K, Melbye M, Ekström Smedby K (2009). "Genetic variation in chromosomal translocation breakpoint and immune function genes and risk of non-Hodgkin lymphoma." (Submitted)
Issue date: 2009-01-30
Rights:
Publication year: 2009
ISBN: 978-91-7409-276-9
Statistics
Total Visits
Views | |
---|---|
Hematolymphoproliferative ...(legacy) | 870 |
Hematolymphoproliferative ... | 287 |
Total Visits Per Month
September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | |
---|---|---|---|---|---|---|---|
Hematolymphoproliferative ... | 10 | 29 | 14 | 16 | 14 | 13 | 23 |
File Visits
Views | |
---|---|
thesis.pdf | 1257 |
thesis.pdf(legacy) | 1180 |
thesis.pdf.txt(legacy) | 2 |
Top country views
Views | |
---|---|
United States | 393 |
China | 95 |
Sweden | 81 |
Germany | 70 |
United Kingdom | 67 |
Ireland | 64 |
Russia | 34 |
South Korea | 30 |
Denmark | 21 |
Finland | 16 |
Top cities views
Views | |
---|---|
Dublin | 64 |
Sunnyvale | 48 |
Beijing | 41 |
Romeo | 38 |
Seoul | 27 |
Kiez | 23 |
Stockholm | 18 |
Ballerup | 16 |
Nürnberg | 11 |
Ashburn | 10 |